357
Participants
Start Date
July 22, 2015
Primary Completion Date
August 18, 2020
Study Completion Date
July 11, 2022
Lenvatinib
Lenvatinib will be administered with water orally once a day (with or without food) continuously in 21-day treatment cycle.
Pembrolizumab
Pembrolizumab will be administered as a dose of 200 mg Q3W, IV in 21-day treatment cycle.
Sørlandet Hospital, Kristiansand
Alaska Clinical Research Center, Anchorage
Arizona Oncology Associates, Oro Valley
Arizona Oncology Associates, PC - HOPE, Site #1, Tucson
Arizona Oncology Associates, PC - HOPE, Site #2, Tucson
Arizona Oncology Associates, PC - HOPE, Site #3, Tucson
Rocky Mountain Cancer Centers, Aurora
Rocky Mountain Cancer Centers, Boulder
Rocky Mountain Cancer Centers, Colorado Springs
Rocky Mountain Cancer Centers, Site #1, Denver
Rocky Mountain Cancer Centers, Site #2, Denver
Rocky Mountain Cancer Centers, Lakewood
Rocky Mountain Cancer Centers, Littleton
Rocky Mountain Cancer Centers, Lone Tree
Rocky Mountain Cancer Centers, Longmont
Rocky Mountain Cancer Centers, Parker
Rocky Mountain Cancer Centers, Pueblo
Rocky Mountain Cancer Centers, Thornton
Baptist Health Medical Group Oncology, LLC, Site #1, Miami
Baptist Health Medical Group Oncology, LLC, Site #2, Miami
Baptist Health Medical Group Oncology, LLC, Site #3, Miami
Boca Raton Clinical Research Medical Center, Plantation
Piedmont Cancer Institue, Atlanta
The University of Chicago, Chicago
Beth Israel Deaconess Medical Center, Boston
Mass General Hospital, Boston
University of Minnesota, Masonic Cancer Center, Minneapolis
Comprehensive Cancer Centers of Nevada, Site #1, Henderson
Comprehensive Cancer Centers of Nevada, Site #2, Henderson
Comprehensive Cancer Centers of Nevada, Site #3, Henderson
Comprehensive Cancer Centers of Nevada, Site #1, Las Vegas
Comprehensive Cancer Centers of Nevada, Site #2, Las Vegas
Comprehensive Cancer Centers of Nevada, Site #3, Las Vegas
Comprehensive Cancer Centers of Nevada, Site #4, Las Vegas
New York Hematology Oncology (US Onc), Albany
Memorial Sloan Kettering at Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
Oregon Health & Science University, Portland
University of Pennsylvania, Philadelphia
Texas Oncology-Bedford, Bedford
Texas Oncology (US Onc), Dallas
Texas Oncology, Dallas
Texas Oncology-Denton South, Denton
Texas Oncology-Fort Worth, Site #1, Fort Worth
Texas Oncology-Grapevine, Grapevine
Texas Oncology-Longview Cancer Center, Longview
Texas Oncology-Plano West, Plano
South Texas Accelerated Research Therapeutics, LLC, San Antonio
Texas Oncology-Tyler, Tyler
Texas Oncology-Waco, Site #1, Waco
Texas Oncology-Waco, Site #2, Waco
Haukeland Univerity Hospital, Bergen
Akershus Universitetssykehus HF, Lørenskog
Oslo Univerity Hospital, Oslo
Sykehuset Østfold, Sarpsborg
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario De Fuenlabrada, Fuenlabrada
Hospital La Paz, Madrid
Hospital Universitario Clinico San Carlos, Madrid
MD Anderson Cancer Center Madrid - España, Madrid
Parc Taulí Sabadell, Sabadell
Hospital Virgen de la Salud, Toledo
Hospital Universitari i Politécnic La Fe., Valencia
Merck Sharp & Dohme LLC
INDUSTRY
Eisai Inc.
INDUSTRY